Who We Are
Novogene is a leading multi-omics services and solutions provider, committed to advancing scientific discovery and accelerating innovation in life sciences, translational medicine, and precision healthcare. Through cutting-edge technologies, world-class laboratory infrastructure, and deep scientific expertise, we empower researchers, clinicians, pharmaceutical and biotechnology companies, and healthcare institutions to unlock the full potential of biological data.
Our integrated portfolio spans genomics, transcriptomics, epigenomics, proteomics, metabolomics, microbiome research, single-cell analysis, spatial biology, and advanced bioinformatics. By combining multi-omics with computational biology and artificial intelligence, we deliver end-to-end solutions that accelerate discovery, biomarker research, drug development, and clinical translation.
Across the Asia-Pacific, Middle East, and Africa (AMEA), Novogene operates sequencing centres in Singapore and Japan, with commercial operations spanning Australia, Hong Kong, South Korea, and beyond. Backed by a global network of laboratories and commercial operations, we collaborate with leading academic institutions, healthcare organisations, government agencies, and industry partners worldwide. Driven by scientific rigour, continuous innovation, and operational excellence, Novogene is a trusted partner in multi-omics, transforming scientific discoveries into real-world impact across human health, agriculture, conservation, and environmental sciences.
